Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis.
Antova, a humanized monoclonal antibody, is used to treat rheumatic conditions like systemic lupus erythematosus and lupus nephritis.